In the end, the power is going to be with the payors, who are plenty savvy themselves, not the pharma companies. Drugs are a relatively small part (10-15%) of

In the end, the power is going to be with the payors, who are plenty savvy themselves, not the pharma companies. Drugs are a relatively small part (10-15%) of the overall cost of healthcare.